Local Radiotherapy for Urinary Bladder Cancer in Patients Not Eligible for Curative Treatment

The goal of this clinical trial is to improve the quality of life and prolong survival in bladder cancer patients unfit for curative treatment. The trial will compare the survival and symptoms of patients randomized to either local radiotherapy in addition to standard of care or standard of care alone. Using modern radiotherapy techniques, including hypofractionation and image-guided treatment adaptation, the aim is to deliver a well-tolerated, time-efficient, and effective treatment strategy for these patients. The trial collaborates with two ongoing exploratory biomarker studies collecting

Trial Details

NCT ID
NCT07524426
Phase
NA
Sponsor
Umeå University
Status
RECRUITING
Cancer Type
Bladder Cancer
Interventions
  • Local hypo fractionated adaptive radiotherapy and Standard of Care
  • Standard of Care (Investigator Choice)
Locations (sample)
  • Umeå, Västerbotten County, Sweden|63.82842,20.25972

Key Eligibility Criteria

  • Oral and written consent
  • Histologically confirmed MIBC with urothelial component
  • Male or female participants ≥ 18 years old
  • Deemed not to benefit from curative treatment at a multidisciplinary tumour conference (MDT) or having declined curative treatment of their own acc…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Bladder Cancer Trials on Trialify →